CO-AGONISTS OF THE GLP-1 AND AMYLIN RECEPTORS

The invention relates to a compound comprising a GLP-1 receptor agonist and an amylin receptor agonist. The invention also relates to a pharmaceutical formulation, suitable for but not limited to oral administration, which comprises such a compound. The compound and pharmaceutical formulation compri...

Full description

Saved in:
Bibliographic Details
Main Authors Schaeffer, Lauge, Oestergaard, Soeren, Tornoee, Christian Wenzel, Madsen, Johnny, Kruse, Thomas, Kodal, Anne Louise Bank, Hogendorf, Wouter Frederik Johan, Madsen, Alice Ravn
Format Patent
LanguageEnglish
Published 19.10.2023
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The invention relates to a compound comprising a GLP-1 receptor agonist and an amylin receptor agonist. The invention also relates to a pharmaceutical formulation, suitable for but not limited to oral administration, which comprises such a compound. The compound and pharmaceutical formulation comprising it may be used for the medical treatment of subjects with overweight, obesity and associated co-morbidities.
Bibliography:Application Number: US202218084088